Skip to content

Exisulind

Drug profile

Also known as: aptosyn, sulindac sulfone

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Exisulind is a drug catalogued in DrugCentral. DrugCentral lists 3 molecular targets, including Akr1b1, EDNRA and MAPK1.

  • Molecular targets: Akr1b1, EDNRA and MAPK1 (3 listed in DrugCentral).
  • Molecular formula: C20H17FO4S; molecular weight 372.42 g/mol.

Mechanism & targets

Molecular targets (3)

TargetGeneActionActivity
Aldose reductaseAkr1b1unknownIC50 6.57
Endothelin-1 receptorEDNRAunknownKi 5.22
Mitogen-activated protein kinase 1MAPK1unknownIC50 4.86

Chemical structure

Full physicochemical, ADMET and 3D-structure analysis of Exisulind is on its molecule page.

Molecular formulaC20H17FO4S
Molecular weight372.42 g/mol
CAS number—
InChIKeyMVGSNCBCUWPVDA-MFOYZWKCSA-N
PubChem CID5472495
CC1=C(CC(O)=O)C2=CC(F)=CC=C2\C1=C/C1=CC=C(C=C1)S(C)(=O)=O

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

How does Exisulind work?

Its molecular targets in DrugCentral include Akr1b1, EDNRA and MAPK1.

What is the chemical formula of Exisulind?

Exisulind has the molecular formula C20H17FO4S and a molecular weight of 372.42 g/mol.

Browse: all drugs starting with E · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

Status—
First approval—
Agency—
Targets3
Indications0
FormulaC20H17FO4S
DrugCentral ID3219
Interactive profile